NDC 66993-135

Fluticasone Furoate and Vilanterol

Fluticasone Furoate And Vilanterol

Fluticasone Furoate and Vilanterol is a Respiratory (inhalation) Powder in the Human Prescription Drug category. It is labeled and distributed by Prasco Laboratories. The primary component is Fluticasone Furoate; Vilanterol Trifenatate.

Product ID66993-135_b7c053e6-82c4-49be-9331-1edcb64439ca
NDC66993-135
Product TypeHuman Prescription Drug
Proprietary NameFluticasone Furoate and Vilanterol
Generic NameFluticasone Furoate And Vilanterol
Dosage FormPowder
Route of AdministrationRESPIRATORY (INHALATION)
Marketing Start Date2022-05-23
Marketing CategoryNDA AUTHORIZED GENERIC /
Application NumberNDA204275
Labeler NamePrasco Laboratories
Substance NameFLUTICASONE FUROATE; VILANTEROL TRIFENATATE
Active Ingredient Strength100 ug/1; ug/1
Pharm ClassesAdrenergic beta2-Agonists [MoA], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], beta2-Adrenergic Agonist [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 66993-135-97

1 TRAY in 1 CARTON (66993-135-97) > 1 INHALER in 1 TRAY > 30 POWDER in 1 INHALER
Marketing Start Date2022-05-23
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Fluticasone Furoate and Vilanterol" or generic name "Fluticasone Furoate And Vilanterol"

NDCBrand NameGeneric Name
66993-135Fluticasone Furoate and Vilanterolfluticasone furoate and vilanterol
66993-136Fluticasone Furoate and Vilanterolfluticasone furoate and vilanterol

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.